Valuation: DIAGNOS Inc.

Market Cap 29.26M 20.43M 18.61M 17.14M 15.59M 1.89B 30.75M 209M 82.93M 1.03B 76.64M 75.03M 3.24B P/E 2025
-6.18x
P/E 2026 -6.51x
Enterprise Value 28.73M 20.06M 18.27M 16.84M 15.31M 1.86B 30.2M 205M 81.44M 1.01B 75.27M 73.68M 3.18B EV / Sales 2025
293x
EV / Sales 2026 498x
Free-Float
94.59%
Yield 2025 *
-
Yield 2026 -
1 day+2.13%
1 week-27.27%
Current month-28.36%
1 month-39.24%
3 months-38.06%
6 months+20.00%
Current year-36.00%
1 week 0.24
Extreme 0.235
0.34
1 month 0.24
Extreme 0.235
0.41
Current year 0.18
Extreme 0.175
0.53
1 year 0.18
Extreme 0.175
0.53
3 years 0.18
Extreme 0.175
0.57
5 years 0.12
Extreme 0.125
0.59
10 years 0.1
Extreme 0.1
2
Manager TitleAgeSince
Chief Executive Officer - -
Director of Finance/CFO - 01/05/2008
Chief Operating Officer - 16/01/2024
Director TitleAgeSince
Director/Board Member - 21/09/2000
Director/Board Member 72 28/09/2020
Chairman 69 30/10/2025
Date Insider Type Main position Quantity % Market Cap. Importance
21/10/26 Buy

Chairman

30,000 0.0249%
28/8/26 Buy

Director

105,000 0.0872%
21/8/26 Option

Director

-100,000 0.0830%
Change 5-day change 1-year change 3-year change Capi.($)
+2.13%-27.27%-18.64%-42.86% 20.44M
+2.65%-7.07%-20.92%+48.79% 212B
+1.10%-15.23%-18.06%-17.98% 151B
+3.26%-9.92%-6.29%-31.81% 129B
-8.85%-9.79%+44.15%+278.91% 109B
-3.73%-11.29%+5.51%+54.83% 94.67B
+1.43%-2.71%-24.51%-32.16% 90.76B
+0.44%-3.03%-1.72%-0.27% 67.56B
+0.56%-4.62%-28.75%-23.62% 47.35B
+0.86%-2.64%-19.14%+2.69% 38.63B
Average -0.00%-9.33%-8.84%+23.65% 94B
Weighted average by Cap. +0.06%-8.03%-7.53%+37.36%

Financials

2025 2026
Net sales 104K 72.47K 66.01K 60.82K 55.33K 6.71M 109K 740K 294K 3.67M 272K 266K 11.5M 65.48K 45.72K 41.64K 38.37K 34.9K 4.23M 68.82K 467K 186K 2.31M 172K 168K 7.26M
Net income -4.29M -2.99M -2.73M -2.51M -2.28M -277M -4.5M -30.57M -12.15M -151M -11.23M -10.99M -475M -4.56M -3.18M -2.9M -2.67M -2.43M -295M -4.79M -32.49M -12.91M -161M -11.93M -11.68M -505M
Net Debt -164K -114K -104K -95.93K -87.26K -10.58M -172K -1.17M -464K -5.78M -429K -420K -18.14M -525K -367K -334K -308K -280K -33.95M -552K -3.75M -1.49M -18.55M -1.38M -1.35M -58.2M
Projected Income Statement - Annual - DIAGNOS Inc.
Logo DIAGNOS Inc.
Diagnos Inc. is a Canadian company, which is engaged in the early detection of critical eye-related health problems using advanced technology based on Artificial Intelligence (AI). It markets Computer Assisted Retinal Analysis (CARA), a software platform which assists health specialists in the detection of certain retinopathy pathologies through the computerized analysis of retina images. CARA is an in-house-hosted Web-based application that integrates fundus cameras with an image processing engine over a secure Internet connection. The CARA suite of applications allows an eye care specialist to more clearly visualize both normal retinal landmarks (optic nerve, vascular system, macula, fovea), and pathological changes (exudates, haemorrhages, micro-aneurisms, neo-vascularization). CARA is indicated for use by healthcare professionals in an adult general population in the context of a general eye-health exam.
Employees
22
Date Price Change Volume
21/11/26 CAD 0.2400 +2.13% 54,917
19/11/26 CAD 0.2350 -14.55% 407,800
18/11/26 CAD 0.2750 -6.78% 219,179
17/11/26 CAD 0.2950 -6.35% 220,250
16/11/26 CAD 0.3150 -4.55% 106,000

Annual profits - Rate of surprise

Rate of surprise - EPS - Annual - DIAGNOS Inc.